BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")

Recruiting now

Conditions studied: Pancreatic Cancer

In brief

No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.

Key facts

Study ID

NCT03311776

Run by

Inna Chen, MD

People needed

5000

Starts

2008-07-03

Expected to finish

2035-07-02

Last updated by the study team

2023-03-01

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage

You may not qualify if…

• None

Where it is running

• Herlev & Gentofte Hospital — Herlev, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.